Gary Brecka

And let's be honest,

When we don't know what to do with some new therapy, we just downplay it and say, oh, we don't have a 10-year randomized controlled trial.

Therefore, it's bad.

No, that means you don't have a 10-year randomized controlled trial.

It's a scientific unknown.

Maybe there's other ways of learning.

Big data, for example.

big data.

We talked about parachutes.

We've never done a randomized clinical trial on parachutes.

Yeah, where's the randomized trial on parachutes?

I mean, you can see it in front of your eyes that it's saving lives, right?

I mean, who wants to be randomized to jump off a plane without a parachute?

I want to see who signs up for that control group.

I want to be in the control group.

I remember, Gary, at Johns Hopkins, and this is to the point that we need to listen to patients and realize that we can learn from patients.

There was a patient with brain cancer, a certain type of incurable glioblastoma multiforme brain cancer at Johns Hopkins.

I didn't know the patient, but this case is well known.

And the guy beat the odds and is a long-term survivor.

You really rarely see a long-term survivor.